UCSF Vascular Symposium
April 10 - 12, 2008 San Francisco,
California
Overview:
This year the Symposium will continue a format that encourages the interaction between participants and speakers. As in past Symposia, recent advances in vascular therapies will be reviewed and their application in various vascular beds examined with respect to durability and cost. This will include the endovascular treatment of arch, thoracic and abdominal aortic aneurysms, innovations in dialysis access, and the treatment of both venous disease and occlusive lesions affecting the lower limbs. This year the review of cerebrovascular disease will use a case presentation format to provide an in-depth examination of the advantages and disadvantages of endarterectomy and stenting for carotid disease. Challenging case presentations also will be included in other sessions to provide a framework for discussions of the various approaches to the problems that confront the practicing Vascular Specialist. The program includes breakout sessions to provide a small group format for discussions with our invited experts and the opportunity for hands-on experience with the devices reviewed during the course.
Upon completion of this symposium, participants should be
able to:
• Discuss current treatment alternatives, surgical and
endovascular, for patients with vascular diseases involving the
carotid, aorta, and infrainguinal arteries
• Delineate the pros and cons of endovascular aneurysm
repair of both abdominal and thoracic aneurysms and the most
current advances, devices, and techniques in this rapidly evolving
field
• Develop an endovascular approach for all aortic
aneurysms including pararenal and thoroaco-abdominal aneurysms
• Review the current status of carotid stenting and
become familiar with the maneuvers, techniques and devices that are
employed in this procedure
• Review the techniques and results of surgical and
endovascular options for lower extremity revascularizations and
limb salvage
• Describe advanced techniques for creating and
maintaining the patency of arterio-venous fistulas for
hemodialysis
• Plan the optimum strategy for treating acute and
chronic venous thrombosis and the late sequella of venous
disease
